AXOVANT GENE THERAPIES LTD

CUSIP: G0750W203 Class: COM

GOLDMAN SACHS GROUP INC's Holding History (CIK: 0000886982)

Note: Option positions (PUT/CALL) are excluded.

Q3 2020
Shares 91,731 Value ($000) $424 Avg Close Range
Q1 2020
Shares 26,839 Value ($000) $65 Avg Close Range
Q4 2019
Shares 10,938 Value ($000) $56 Avg Close Range
Q3 2019
Shares 18,313 Value ($000) $118 Avg Close Range
Q2 2019
Shares 10,731 Value ($000) $67 Avg Close Range